Biotech Harbour BioMed and Insilico Medicine Achieve Strategic Collaboration to Advance AI-Driven Antibody Discovery and Development February 21, 2025
Biotech BioArctic’s global license agreement with Bristol Myers Squibb for PyroGlutamate-amyloid-beta antibody program effective after antitrust clearance and closing February 20, 2025
Biotech Enzymatica AB Year-end report 2024: Strong performance in core markets – preparing for international growth February 19, 2025
Biotech The Galien Foundation Announces New Prix Galien UK Award Category for “Best Health Equity Innovation” February 18, 2025
Biotech Innovent Receives Second Fast Track Designation from the U.S. FDA for IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Squamous Non-Small Cell Lung Cancer February 17, 2025
Biotech Dignify Therapeutics Highlights Clinical Development Plans at BIO CEO & Investor Conference February 16, 2025
Biotech Aramis Biotechnologies and the Biologics Manufacturing Centre Announce a Partnership February 15, 2025
Biotech DAAN Biotherapeutics Signs Antibody Exclusive Licensing Agreement with LigaChem Biosciences for ADC (Antibody-Drug Conjugate) Therapeutic Development February 13, 2025
Biotech Jazz Pharmaceuticals to Report 2024 Full Year and Fourth Quarter Financial Results on February 25, 2025 February 12, 2025